A sluggish Q1 2016
The pharmaceutical laboratory recorded a slight 0.47% decline in revenues to TND20.91m (vs. TND20.81m in Q1 2015), mainly pulled down by a 3.1% decrease in Generics sales to TND7.26m. Branded products’ sales have witnessed a slight increase of 0.4% to TND12.39m. However, Hospital Model’s revenues have fallen by 10.5% to TND862k. Total production dropped by 1.2%. Investments amounted to TND0.72m against TND0.91m in Q1 2015, a 20.7% decline on a yoy basis.
AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.